Lu Cao

493 total citations
16 papers, 341 citations indexed

About

Lu Cao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lu Cao has authored 16 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Lu Cao's work include Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Lu Cao is often cited by papers focused on Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Lu Cao collaborates with scholars based in China. Lu Cao's co-authors include Yun Niu, Cong Xu, Lingmei Li, Wenfeng Cao, Jiao Jiao, Lisha Qi, Xiaozhen Liu, Wangzhao Song, Yalei Wang and Yuhong Guo and has published in prestigious journals such as American Journal Of Pathology, Molecular Cancer and Cancer Letters.

In The Last Decade

Lu Cao

16 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu Cao China	12	219	115	103	69	41	16	341
Kiyoung Eun South Korea	8	258 1.2×	181 1.6×	122 1.2×	32 0.5×	35 0.9×	16	395
Maria A. Voronkova United States	9	280 1.3×	119 1.0×	114 1.1×	56 0.8×	21 0.5×	15	452
Cera Nieto United States	9	198 0.9×	136 1.2×	101 1.0×	89 1.3×	28 0.7×	10	349
Trevor G. Levin United States	6	147 0.7×	189 1.6×	74 0.7×	30 0.4×	45 1.1×	15	314
Sonali Bhattacharjee United States	7	262 1.2×	70 0.6×	91 0.9×	28 0.4×	30 0.7×	8	388
E. Josue Ruiz United Kingdom	8	228 1.0×	122 1.1×	97 0.9×	58 0.8×	11 0.3×	9	325
Shaoqiang Cheng China	7	174 0.8×	118 1.0×	115 1.1×	41 0.6×	16 0.4×	11	320
Anurag N. Paranjape United States	8	349 1.6×	273 2.4×	145 1.4×	99 1.4×	34 0.8×	16	503
Robiya Joseph United States	8	244 1.1×	133 1.2×	134 1.3×	67 1.0×	14 0.3×	18	362

Countries citing papers authored by Lu Cao

Since Specialization

Citations

This map shows the geographic impact of Lu Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Cao more than expected).

Fields of papers citing papers by Lu Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Cao. The network helps show where Lu Cao may publish in the future.

Co-authorship network of co-authors of Lu Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Cao. A scholar is included among the top collaborators of Lu Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Cao. Lu Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cai, Gang, Keman Liao, Jian Yang, et al.. (2025). Targeting PGE2 mediated senescent neuron improves tumor therapy. Neuro-Oncology. 27(6). 1491–1506. 1 indexed citations

Zhang, Wenshuai, Danyang Ren, Yalei Wang, et al.. (2023). ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma. Journal of Translational Medicine. 21(1). 341–341. 25 indexed citations

Cao, Lu, et al.. (2022). Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis. Breast Cancer Research and Treatment. 197(1). 71–82. 3 indexed citations

Cao, Lu & Yun Niu. (2020). Triple negative breast cancer: special histological types and emerging therapeutic methods. Cancer Biology and Medicine. 17(2). 293–306. 63 indexed citations

Zhang, Wenshuai, Lisha Qi, Lu Cao, et al.. (2020). ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression. Cell Death and Disease. 11(7). 511–511. 21 indexed citations

Cao, Lu, et al.. (2019). A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer. Cancer Chemotherapy and Pharmacology. 84(3). 609–620. 20 indexed citations

Cao, Lu, et al.. (2019). RF2 basic leucine zipper transcription factor TabZIP3 involved in salt stress response in wheat.. Zhongguo nongye ke-ji daobao. 21(6). 20–27. 4 indexed citations

Xu, Cong, Fang Liu, Lu Cao, et al.. (2019). β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 238–238. 14 indexed citations

Wang, Li, Cong Xu, Xia Liu, et al.. (2019). TGF-β1 stimulates epithelial–mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer. Cancer Cell International. 19(1). 343–343. 13 indexed citations

10.

Cao, Lu, et al.. (2018). Clinical significance of PDEF factor expression and its relation to androgen receptor in ER⁻ breast cancer. Histopathology. 73(5). 819–831. 9 indexed citations

11.

Cao, Lu, Cong Xu, Xiaozhen Liu, et al.. (2018). AR–PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer. Molecular Cancer. 17(1). 136–136. 18 indexed citations

12.

Liu, Xiaozhen, Junjun Liu, Lu Cao, et al.. (2018). Androgen receptor and heat shock protein 27 co-regulate the malignant potential of molecular apocrine breast cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 90–90. 21 indexed citations

13.

Li, Lingmei, Lisha Qi, Changxu Liu, et al.. (2018). Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma. American Journal Of Pathology. 188(8). 1882–1894. 21 indexed citations

14.

Cao, Lu, Lisha Qi, Lin Zhang, et al.. (2017). Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ß signaling pathway in lung adenocarcinoma. Cancer Letters. 403. 246–259. 40 indexed citations

15.

Li, Congying, Lu Cao, Cong Xu, et al.. (2017). The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer. Human Pathology. 75. 16–25. 26 indexed citations

16.

Qi, Lisha, Wangzhao Song, Lingmei Li, et al.. (2016). FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma. Oncotarget. 7(45). 74015–74030. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact